Ticker: GH

Guardant Health, Inc. (NASDAQ: GH) Overview Guardant Health is a precision oncology company dedicated to enhancing cancer care through innovative blood and tissue tests. As of March 31, 2025, the company reported a total revenue of $203.5 million, showcasing a remarkable growth of 21% compared to...